GlassScriptPhysician profile
Berenice Monarez
NPI 1649720087
$6,602.30
in general payments reported to CMS, 2019-2025
30 companies · $1,869 in 2025
The $1,869 reported for 2025 was more than what 94% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $754 · 2022: $1,377 · 2023: $912 · 2024: $1,690 · 2025: $1,869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,278 · Education: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,278.29 |
| Education | $192.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,315.81 | 2021-2025 | Airsupra, Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $1,275.67 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $581.63 | 2022-2025 | Dupixent |
| Grifols USA, LLC | $294.70 | 2021-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $219.20 | 2023-2025 | |
| Viatris Specialty LLC | $190.20 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $172.32 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $167.41 | 2021-2025 | Ofev, Jascayd |
| Vapotherm INC | $156.63 | 2022 | |
| Janssen Pharmaceuticals, INC | $120.56 | 2024 | Xarelto |
| Inspire Medical Systems, INC. | $120.40 | 2025 | Inspire |
| Mylan Specialty L.P. | $120.25 | 2021-2024 | Yupelri |
| Insmed, INC. | $119.66 | 2023-2025 | Arikayce, Brinsupri |
| Neurocrine Biosciences, INC. | $99.99 | 2025 | |
| Verona Pharma, INC. | $86.13 | 2025 | Ohtuvayre |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $83.24 | 2022-2025 | Tezspire, Tavneos |
| Baxter Healthcare | $58.41 | 2022 | |
| Mallinckrodt Hospital Products INC. | $55.17 | 2025 | Acthar |
| Inogen, INC. | $51.60 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Advanced Respiratory, INC | $49.04 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $38.03 | 2021 | |
| La Jolla Pharmaceutical Company | $36.03 | 2022 | |
| Electromed, INC. | $32.32 | 2025 | Smartvest |
| United Therapeutics Corporation | $29.71 | 2023 | Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $24.35 | 2024 | Glassia |
| Tactile Systems Technology INC | $24.17 | 2025 | Nimbl, Flexitouch Plus |
| Alexion Pharmaceuticals, INC. | $23.32 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $21.51 | 2024 | Uptravi, Opsumit |
| Philips North America LLC | $20.78 | 2024 | (Ak6) Vest Therapy |
| Gilead Sciences, INC. | $14.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Berenice Monarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.